Series Papers
description
Transcript of Series Papers
HIV-Related Disparities AmongBlack MSM and Associations with
Structural Factors
Gregorio MillettCenters for Disease Control and Prevention
Washington, DCJuly 24, 2012
Series PapersMeta-Analysis 1
• Purpose:1. Explain HIV-related racial disparities
among US MSM• HIV-positive MSM • young MSM
2. Are there similar racial disparities among MSM in Canada, UK and US?
• Sample: – 106,148 black MSM and 581577 MSM of other
races/ethnicities– 174 US studies, 13 UK studies and 7 US studies
Meta-Analysis 2
• Purpose:1. Estimate HIV prevalence
• black MSM vs. general populations• black populations across the world
2. Assess HIV prevalence among black MSM by African and Caribbean countries that criminalize homosexual behavior
• Sample – 129,976 black MSM in North America,
Caribbean, Europe and Africa
HIV Prevalence Among Black MSM vs. General Black Populations Across Diaspora
HIV prevalence disparities among black MSM vs. general populations
• U.S. 72x more likely to be HIV+
• Canada 73X more likely to be HIV+
• UK111X more likely to be HIV+
HIV Risk Behavior & HIV InfectionBlack vs. Other MSM, U.S. & U.K.
Structural-Level Experiences &Resiliency, U.S. Black MSM vs. Other MSM
0tan28a566028
0tan29a566029
0tan1a56601
0tan2a56602
0tan3a56603
0tan4a56604
HIV
Prev
alen
ce S
umm
ary
Odd
Rati
o
HIV-Related Summary ORs by Rank– Black MSM vs. Other MSM
Partner characteristicsStructural inequalitiesHIV clinical outcomes
Sexual risk behaviorsDrug useNongay identityCircumcision
Diagnosed HIV+OR, 3.00 (2.06-4.40)
Undiagnosed HIVOR, 6.38 (4.33-9.39)
>200 CD4 cells/mm3 before
ART initiation OR, 0.40 (0.26-0.62)
ART adherenceOR, 0.50 (0.33-0.76)
HIV suppressionOR, 0.51 (0.31-0.83)
ART utilization/ accessOR, 0.56 (0.41-0.76)
HIV Detection
Viral Suppression
(Millett, 2012)
Disparities persist between black and other MSM throughout treatment cascade
Diagnosed HIV+OR, 3.00 (2.06-4.40)
Undiagnosed HIVOR, 6.38 (4.33-9.39)
Health insurancecoverage
OR,0.47 (0.29-0.77)
>200 CD4 cells/mm3 before
ART initiation OR, 0.40 (0.26-0.62)
ART adherenceOR, 0.50 (0.33-0.76)
HIV suppressionOR, 0.51 (0.31-0.83)
ART utilization/ accessOR, 0.56 (0.41-0.76)
HIV Detection
Viral Suppression
Healthcare visits
OR, 0.61 (0.42-0.90)
Lower income (<$20k)
OR, 3.42 (1.94-6.01)
(Millett, 2012)
Criminalization of Homosexuality & HIV Prevalence Disparities by Region
Overall sample• No difference in
– Serodiscordant sex– Perceived susceptibility/ tx optimism– Sex network variables (eg, concurrency,
same-race partners)
• Greater risk of serconversion even if engage in serosorting/strategic positioning
• Less– Sex during drug use– Poppers– Amphetamines– Any drugs associated with HIV
infection
Young Black vs. Other Young MSM• Less likely to engage in
– Any substance use– Amphetamine use– Injection drug use – Crack cocaine use– Sex during drug use
• Yet, more likely to have HIV (5x), STI (7x), undiagnosed HIV (45% greater likelihood)
• HIV-related factors for young black MSM– Young sex debut (65% greater)– Childhood sexual abuse (82% greater)– Older sex partners (52% greater)
Other Noteworthy Findings
• Black MSM – 8.5x more likely to be HIV+ vs. black populations
worldwide– 15x more likely to be HIV+ vs. general
populations
• Risk behavior does not explain HIV disparities in UK or US black MSM, and late ART access for black MSM in both countries
• Disparities greatest for structural, clinical, network variables associated with HIV infection
– Future interventions must focus here
• Black MSM 40% more likely to engage in any protective behavior, despite greater exposure to any structural barrier
• Criminalization of homosexual activity is associated with a 2-fold increase in HIV prevalence among black MSM across African and Caribbean countries— Association only statistically significant for
Caribbean countries
• Both reviews establish • Similar patterns in greater risk for HIUV
infection among black MSM across countries
• Addressing structural barriers is essential to eliminating disparities and achieving health equity for black MSM at higher risk for HIV infection worldwide and should be targeted for HIV prevention and care efforts
Summary
• John Peterson, USA• Stephen Flores, USA• William Jeffries, USA• Charles Heilig, USA• Trevor Hart, Canada• Tim Lane, USA• Robert Remis, Canada
• David Malebranche, USA• Sean Rourke, Canada• Patrick Wilson, USA• Jonathan Elford, UK• Kevin Fenton, USA• Riley Steiner, USA
Acknowledgments